Derek Rodrigues, MD
Clinical Cardiac Electrophysiology · Bellevue, WANPI 1194736041
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,635 of the $28,318 with a category attached, or 69.3%. 24 manufacturers reported payments, led by Medical Device Business Services, Inc. at 42.4% of the total. Reporting peaked in 2024 at $11,933 and has fallen 82.3% since, to $2,107 in 2025.
Across 123 payments — averaging $230.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$12K
- Siemens Medical Solutions USA, Inc.$8K
- Boston Scientific$4K
- Fujifilm Sonosite, Inc.$1K
- Medtronic$1K
- Biosense Webster, Inc.$768
- plus $1K from 18 others
What the payments were for
- Consulting fees$19,63569%
- Speaking & faculty fees$1,7006%
- Travel & lodging$2,73210%
- Food & beverage$4,25115%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 11 | $12,000 |
| Siemens Medical Solutions USA, Inc. | 6 | $8,135 |
| Boston Scientific | 33 | $3,691 |
| Fujifilm Sonosite, Inc. | 2 | $1,200 |
| Medtronic(2 entities) | 9 | $1,055 |
| Biosense Webster, Inc. | 27 | $768 |
| Abbott | 4 | $443 |
| Biotronik Inc. | 2 | $170 |
| Acutus Medical, Inc. | 1 | $131 |
| Cortex, Inc. | 1 | $129 |
| AstraZeneca | 5 | $90 |
| Pfizer | 3 | $73 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $61 |
| Johnson & Johnson | 2 | $50 |
| Amgen | 2 | $47 |
| Cardiva Medical, Inc. | 2 | $45 |
| Novo Nordisk | 2 | $45 |
| Bridgebio Pharma, Inc. | 1 | $35 |
| Stryker | 1 | $34 |
| Novartis | 1 | $30 |
| Ablacon, Inc. | 1 | $26 |
| ZOLL Respicardia, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Teleflex LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$12,000
- ACUSON Origin Diagnostic Ultrasound System$2,040
- ACUSON Sequoia Diagnostic Ultrasound System$1,700
- SC2000$1,160
- WATCHMAN Access System$844
- Micra$833
- Sequoia$700
- Sonosite MT$700
- PX Ultrasound System$500
- S-ICD System Magnet$405
- EMBLEM MRI S-ICD$241
- Confirm Rx$171
- AVEIR$161
- RESONATE EL ICD VR$125
- Farapulse$121
- OCTARAY MAPPING CATHETER$120
- Soundstar$120
- ENSITE PRECISION$100
How this compares
$28,318 in reported general payments places this provider in the 75th percentile of 68 clinical cardiac electrophysiology providers in Washington.
See all clinical cardiac electrophysiology providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 390 | $502,422 |
| XareltoRivaroxaban | 89 | $130,237 |
| MultaqDronedarone Hcl | 67 | $74,781 |
| EntrestoSacubitril/Valsartan | 17 | $24,110 |
| Dofetilide | 25 | $6,281 |
| Flecainide Acetate | 209 | $5,312 |
| Metoprolol Succinate | 220 | $3,193 |
| SotalolSotalol Hcl | 87 | $1,645 |
| Diltiazem 12hr ErDiltiazem Hcl | 11 | $1,630 |
| Losartan Potassium | 109 | $1,373 |
| Atorvastatin Calcium | 201 | $1,350 |
| Amiodarone Hcl | 56 | $1,239 |
| Rosuvastatin Calcium | 78 | $1,119 |
| Propafenone Hcl | 24 | $1,104 |
| Valsartan | 13 | $688 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $73 | $502,422390 claims |
| Johnson & JohnsonXarelto | $50 | $130,23789 claims |
| NovartisEntresto | $30 | $24,11017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 68 clinical cardiac electrophysiology providers in Washington.
Other clinical cardiac electrophysiology in Bellevue
- Maheer GandhavadiBellevue$118K
- Jeffrey FowlerBellevue$12K
- John HeywoodBellevue$5K
- Gust BardySeattle$130.7M
- Babak NazerSeattle$124K
- Toshimasa OkabeSeattle$114K
- Darryl WellsSeattle$112K
- Arun R Mahankali SridharSeattle$94K
- Jeanne PooleSeattle$81K
- Amier AhmadSunnyside$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.